Ling Xu

6.5k total citations · 2 hit papers
98 papers, 3.1k citations indexed

About

Ling Xu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ling Xu has authored 98 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 42 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Ling Xu's work include Immune Cell Function and Interaction (29 papers), CAR-T cell therapy research (25 papers) and T-cell and B-cell Immunology (13 papers). Ling Xu is often cited by papers focused on Immune Cell Function and Interaction (29 papers), CAR-T cell therapy research (25 papers) and T-cell and B-cell Immunology (13 papers). Ling Xu collaborates with scholars based in China, United States and Montenegro. Ling Xu's co-authors include Yangqiu Li, Dongliang Yang, Mengji Lu, Xin Zheng, Jia Liu, Dimitri Kasakovski, Shaohua Chen, Jiaxiong Tan, Chengwu Zeng and Lijian Yang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ling Xu

92 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver injury during highly pathogenic human coronavirus infections

2020 614 citations Ling Xu, Jia Liu et al. profile →
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy

2023 195 citations Jiaxiong Tan, Ling Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling Xu China	27	977	937	861	751	333	98	3.1k
Duck Cho South Korea	29	1.3k 1.3×	1.0k 1.1×	464 0.5×	635 0.8×	370 1.1×	205	3.0k
Chyi‐Chia Richard Lee United States	40	1.8k 1.8×	2.0k 2.1×	2.0k 2.3×	474 0.6×	496 1.5×	114	5.4k
Su‐Hyung Park South Korea	36	1.9k 1.9×	1.2k 1.3×	818 1.0×	894 1.2×	946 2.8×	116	4.2k
Philippe Delvenne Belgium	30	596 0.6×	563 0.6×	848 1.0×	270 0.4×	699 2.1×	113	2.9k
Lynn Sorbara United States	32	762 0.8×	1.7k 1.8×	686 0.8×	184 0.2×	381 1.1×	58	4.0k
Hossein Khorramdelazad Iran	29	905 0.9×	665 0.7×	662 0.8×	237 0.3×	367 1.1×	124	2.5k
David B. Sykes United States	30	1.1k 1.1×	649 0.7×	1.7k 2.0×	222 0.3×	283 0.8×	118	3.5k
Nienke Vrisekoop Netherlands	25	2.1k 2.1×	742 0.8×	868 1.0×	244 0.3×	401 1.2×	68	3.6k
Christoph Hess Switzerland	37	3.0k 3.1×	1.3k 1.4×	1.6k 1.9×	317 0.4×	559 1.7×	95	5.5k
Fridtjof Lund‐Johansen Norway	35	2.4k 2.5×	706 0.8×	1.1k 1.3×	656 0.9×	289 0.9×	94	4.9k

Countries citing papers authored by Ling Xu

Since Specialization

Citations

This map shows the geographic impact of Ling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xu more than expected).

Fields of papers citing papers by Ling Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xu. The network helps show where Ling Xu may publish in the future.

Co-authorship network of co-authors of Ling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xu. A scholar is included among the top collaborators of Ling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xu. Ling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Zhenzhen, et al.. (2025). CRISPR-Cas for hepatitis virus: a systematic review and meta-analysis of diagnostic test accuracy studies. Frontiers in Microbiology. 16. 1509890–1509890.

Yu, Xibao, et al.. (2024). CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. ImmunoTargets and Therapy. Volume 13. 1–14. 14 indexed citations

Wang, Hua, Boyun Liang, Sumeng Li, et al.. (2024). Omicron breakthrough infections after triple‐dose inactivated COVID‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses. Immunology. 172(2). 313–327. 1 indexed citations

Li, Yang, Yan Zhang, Ling Xu, et al.. (2024). Unraveling the Core Components and Critical Targets of Houttuynia cordata Thunb. in Treating Non-small Cell Lung Cancer through Network Pharmacology and Multi-omics Analysis. Current Pharmaceutical Design. 31(7). 540–558.

Xu, Ling, Yu Zhang, Xudong Liu, et al.. (2024). Bioinformatics Analysis of Gene Modules and Key Genes for the Early Diagnosis of Gastric Cancer. 4(1). 24–36.

Xu, Ling, Yu Zhang, Xudong Liu, et al.. (2024).  Mining of Gene Modules and Identification of Key Genes for Early Diagnosis of Gastric Cancer. 13(1). 26–38. 1 indexed citations

Ma, Lei, Shaoying Ma, Xu Lu, et al.. (2023). New insights into the occurrence of continuous cropping obstacles in pea (Pisum sativum L.) from soil bacterial communities, root metabolism and gene transcription. BMC Plant Biology. 23(1). 226–226. 9 indexed citations

Chen, Cunte, Si‐Yang Maggie Liu, Yedan Chen, et al.. (2022). Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer Immunology Immunotherapy. 72(5). 1261–1272. 1 indexed citations

Jin, Ying, Xiaoyu An, Binchen Mao, et al.. (2022). Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment. Scientific Reports. 12(1). 3278–3278. 40 indexed citations

10.

Yao, Danlin, Ling Xu, Jing Lai, et al.. (2020). Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia. BioMed Research International. 2020(1). 9531549–9531549. 14 indexed citations

11.

Jin, Zhenyi, Yun Zhao, Jie Chen, et al.. (2020). Higher TIGIT ⁺ CD226 ^- γδ T cells in Patients with Acute Myeloid Leukemia. Immunological Investigations. 51(1). 40–50. 34 indexed citations

12.

Yao, Danlin, Dimitri Kasakovski, Yikai Zhang, et al.. (2019). Age related human T cell subset evolution and senescence. Immunity & Ageing. 16(1). 24–24. 142 indexed citations

13.

Wang, Xu, Shuai Lu, Ling Xu, et al.. (2018). Alteration of gene expression profile in CD3<sup>+</sup> T-cells after downregulating MALT1. ImmunoTargets and Therapy. Volume 7. 77–81. 1 indexed citations

14.

Tan, Jiaxiong, Shaohua Chen, Yuhong Lu, et al.. (2017). Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia. Chinese Journal of Cancer Research. 29(5). 463–470. 70 indexed citations

15.

Shi, Li, Shaohua Chen, Xianfeng Zha, et al.. (2015). Enhancement of the TCRζ Expression, Polyclonal Expansion, and Activation of T Cells from Patients with Acute Myeloid Leukemia After IL-2, IL-7, and IL-12 Induction. DNA and Cell Biology. 34(7). 481–488. 11 indexed citations

16.

Zeng, Chengwu, Yan Xu, Ling Xu, et al.. (2014). Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells. BMC Cancer. 14(1). 693–693. 170 indexed citations

17.

Shi, Li, Shaohua Chen, Yuhong Lu, et al.. (2013). Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML. Cancer Cell International. 13(1). 37–37. 15 indexed citations

18.

Xu, Ling, Zhiyong Ke, Libin Huang, et al.. (2011). Five Chinese Pediatric Patients with Leukemias Possibly Arising from Immature Natural Killer Cells: Clinical Features and Courses. Pediatric Hematology and Oncology. 28(3). 187–193. 5 indexed citations

19.

Wang, Zengyan, Ling Xu, & Fang-Fang He. (2010). Embryo vitrification affects the methylation of the H19/Igf2 differentially methylated domain and the expression of H19 and Igf2. Fertility and Sterility. 93(8). 2729–2733. 89 indexed citations

20.

Luo, Xue‐Qun, et al.. (2008). High-Dose Chemotherapy without Stem Cell Transplantation for Refractory Childhood Systemic Lupus Erythematosus. Chemotherapy. 54(5). 331–335. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact